5
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3589 |
NSC23005 Sodium
|
CDK | Cell Cycle/Checkpoint |
NSC23005 sodium 是新型 p18 抑制剂 (ED50=5.21 nM),在小鼠和人类模型中促进造血干细胞扩增。 | |||
T21493 |
Cyclosporin H
|
Others | Others |
Cyclosporin H 是一种 FPR-1(甲酰肽受体 1) 的选择性强效抑制剂。它缺乏 Cyclosporin A 具有的免疫抑制活性。它是一种病毒转导增强剂,可使人脐带血来源的造血干细胞和祖细胞中慢病毒转导增强 10 倍。它与雷帕霉素或前列腺素 E2 联合使用时表现出累加效应。 | |||
T76748 | Foralumab | ||
Foralumab(NI-0401)为口服有效的人源化单克隆抗体,针对CD3进行靶向。其能够调控NSG小鼠体内,由人类造血干细胞重建的人类细胞的免疫反应。 | |||
T35568 |
BODIPY-aminoacetaldehyde diethyl acetal
|
||
BODIPY-aminoacetaldehyde diethyl acetal (BAAA-DA) is a stable precursor to BODIPY-aminoacetaldehyde, a cell-permeable fluorescent substrate for aldehyde dehydrogenase (ALDH).1,2BODIPY-aminoacetaldehyde diethyl acetal is converted under acidic conditions to BODIPY-aminoacetaldehyde (BAAA).2BAAA is cell-permeant and is converted intracellularly by ALDH to BODIPY aminoacetate (BAA), which is retained by cells and can be used to identify cells with high ALDH activity.1BAA is a substrate for the effl... | |||
T83763 |
EPI-X4 TFA
Endogenous Peptide Inhibitor of CXCR4 |
||
EPI-X4是一种源于人血清白蛋白408-423氨基酸的内源性肽段,是趋化因子(C-X-C基序)受体4 (CXCR4)的拮抗剂。在0.8至1,000µM的浓度范围内,EPI-X4能抑制表达CXCR4的HEK293细胞中由趋化因子(C-X-C基序)配体12 (CXCL12)诱发的钙离子动员和受体内化。EPI-X4还能抑制CXCL12诱导的Jurkat T细胞和人类CD34+造血干细胞的迁移。体内实验中,EPI-X4(16µmol/kg)在急性过敏性气道高嗜酸性粒细胞疾病的小鼠模型中减少了Cxcr4依赖的炎症细胞气道浸润。慢性肾脏病患者尿液中EPI-X4的水平增高,并与肾小球滤过率(GFR)成反比。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN2883 |
3',4'-Dimethoxyflavone
|
Others; PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair; Others |
3',4'-Dimethoxyflavone 是类黄酮化合物的参考标准,类黄酮化合物具有多种药用活性。 |